India's Serum Institute to boost vaccine exports gradually, report says

The Serum Institute of India, which produces the AstraZeneca COVID-19 vaccine, will resume small exports via the global vaccine-sharing platform COVAX this month and raise it substantially by January, its head told The Telegraph.

migrator

Updated:1st Oct, 2021 at 1:57 PM

New Delhi

"Our exports to COVAX will recommence again in October, initially these supplies will be small but by January 2022, once we have satisfied domestic demands – people forget that India is still a lower-middle-income country – we will see large volumes go to COVAX," Chief Executive Adar Poonawalla said.

Visit news.dtnext.in to explore our interactive epaper!

Download the DT Next app for more exciting features!

Click here for iOS

Click here for Android

India's Serum Institute to boost vaccine exports gradually, report says

The Serum Institute of India, which produces the AstraZeneca COVID-19 vaccine, will resume small exports via the global vaccine-sharing platform COVAX this month and raise it substantially by January, its head told The Telegraph.

Also Read

Tamil Nadu rushes to fill statutory posts ahead of poll code; LoP to miss meet

The humble life of honest Padma, the Chennai worker who returned gold worth lakhs

Rajasthani-Tamil Seva Awards return with expanded honours

When a library shuts, it feels like losing a parent: What the British Council means to generations of Chennai readers

Chennai Citizen Connect: Burning garbage under railway flyover creates health concerns in Chengai